Dsicover a recent study that compared Stockholm3 with other established biomarkers for prostate cancer screening. Learn more.

Prostate cancer has distinct genetic properties in different groups of men that can be targeted to improve patient outcomes, ...

A biomarker, PROSTOX, predicted late genitourinary toxicity accurately in patients with prostate cancer, yielding an area under the curve of 0.76.

Prostate cancer has distinct genetic properties in different groups of men that can be targeted to improve patient outcomes, UVA Cancer Center researchers have discovered.

Kairos Pharma (NYSE American: KAPA) , a clinical-stage biopharmaceutical company, issued a shareholder letter from CEO John Yu, M.D., outlining recen ...

Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical stage biopharmaceutical company, today provides a letter to stockholders from CEO John Yu, M.D.: ...

An AI-powered blood test for detecting 12 common cancers has been awarded government funding for further clinical trials.

Dr. Bruce Montgomery, a UW Medicine oncologist, hopes that patients won't see these numbers and just throw up their hands in fear or resignation.

Pancreatic cancer is a leading cause of cancer-related death, with a five-year survival rate of 13%. The high mortality is ...

"Prostate cancer is a worldwide problem. It is the most common cancer in men, with clear racial disparities,” said researcher ...

The global genomic cancer panel and profiling market is rapidly expanding due to advancements in precision medicine, next-generation sequencing (NGS) ...